Article No
30-1472-0.1
CD17 / Lactosylceramide
Anti-CD17 / Lactosylceramide Monoclonal Antibody (Clone:MEM-68)
Antibodies Primary
Specifications
| Application | FC |
| Article No | 30-1472-0.1 |
| Country Availability | SE, FI, DK, NO, IS, EE, LV, LT |
| Clone | MEM-68 |
| Clone Type | monoclonal |
| Conjugation | Unconjugated |
| Description | Anti-CD17 / Lactosylceramide Monoclonal Antibody (Clone:MEM-68) |
| Supplier | Abeomics |
| Immunogen | Pre-B cell line NALM-6 |
| Isotype | IgM |
| Notes | CD17, lactosylceramide, is an ubiquitous glycosphingolipid with uncharged disaccharide headgroup, highly enriched in lipid raft-derived structures. Besides playing a pivotal role in the biosynthesis of complex glycosphingilipids, lactosylceramide is involved in cell-cell and cell-matrix interactions and in signaling events linked to cell differentiation, development, apoptosis and oncogenesis. Lactosylceramide regulates integrin functions and production of nitric oxide. Its expression defines successive stages in the maturation of myeloid cells. |
| Product Type | Antibodies Primary |
| Protocol | Flow Cytometry Recommended dilution:2 µg/ml |
| Purification | Purified |
| Shipping Information | Blue Ice |
| Size | 0.1 mg |
| Source / Host | mouse |
| Species Reactivity | human |
| Storage | 4°C |
| Product Page Updated | 2024-02-06T07:35:53.072Z |
